Vanda Pharmaceuticals Earnings: Here’s Why Shares are Up Now

Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) had a loss and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are up 0.82%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Vanda Pharmaceuticals, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share increased to $-0.15 in the quarter versus EPS of $-0.28 in the year-earlier quarter.

Revenue: Decreased 0.49% to $8.1 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Vanda Pharmaceuticals, Inc. reported adjusted EPS loss of $0.15 per share. By that measure, the company beat the mean analyst estimate of $-0.25. It missed the average revenue estimate of $8.42 million.

Quoting Management: There was no comment from management.

Key Stats (on next page)…

Revenue increased 2.27% from $7.92 million in the previous quarter. EPS increased to $-0.15 in the quarter versus EPS of $-0.23 in the previous quarter.

Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.19 to a loss $0.25. For the current year, the average estimate has moved down from a loss of $0.65 to a loss of $0.89 over the last ninety days.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)

More Articles About:   , , ,  

More from The Cheat Sheet